Company intelligence / Profile preview

MiLaboratories

San Francisco, California, United Statesmilaboratories.com ↗

Ownership: Private
Development stage: Other

Overview

MiLaboratories is a leading provider of computational biology platforms focused on immune repertoire sequencing and next-generation sequencing data analysis. Its flagship products—MiXCR and the new Platforma.bio SDK—are widely adopted by academic researchers and major pharmaceutical companies to accelerate R&D in vaccines, CAR-T therapies, antibody discovery, and other fields. Over 10 million samples have been processed using their tools. The company has strategic partnerships with industry leaders like Miltenyi Biotec.

Modalities: RNA kit technologySoftware platform for immune repertoire profiling and NGS data analysis
Industry: Drug Discovery Services

Partnerships

Miltenyi Biotec

Beyond the preview

Go deeper on MiLaboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MiLaboratories.

Explore the full profile